Back to Trades
CROSS HERB
Chief Financial OfficerCIK 0001230721
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, CROSS HERB, Chief Financial Officer, has disclosed $165.6K in transactions — all concentrated in Jasper Therapeutics, Inc. (JSPR). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jan 5 | JSPR Jasper Therapeutics, Inc. | CROSS HERB | Chief Financial Officer | Award | $165.6K |
1 filing